Clinical observation in temozolomide combined with radiotherapy in treatment of postoperative malignant glioma

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 11, 2008, Pages 843-845

  Wang, Qiong ^a   Wang, Nan Yao ^a   Sheng, Hua Ming ^a   Fei, Yan Hua ^a   Wu, Dan ^a   Shen, Dang ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Brain neoplasms therapy; Dacarbazine therapeutic uses; Glioma therapy; Radiotherapy, conformal

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT RESPONSE;

EID: 77953425734     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Randes A A, Ermani M, Basso U, et al. Temozolomide as a secondline systemic regimen in recurrent high-grade glioma: a phase II study[J]. Ann Onclo, 2001, 12(2):255-257.
2. Stupp R, Dietrich P Y, Ostermann K, et al. Promising survival for patients with newly diagnosed glioblastoma multiform treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide[J]. J Clin Onclo, 2002,20(5):1375-1382.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Chinese source.
7. Chinese source.
8. Chinese source.
9. Corsa P, Parisi S, Raguso A, et al. Temozolimide and radiotherapy as first-line treatment of high-grade gliomas[J]. Tumori, 2006, 92(4):299-305.
10. Papuashvili G S, Gagua R O, Ninua N G. Temozolomide-a new antitumor preparation in the treatment of central nervous system malignant tumor[J]. Georgian Med News, 2006, (134): 31-34.